The Genesis Research Foundation respects your privacy. We protect your personal information and adhere to all legislative requirements with respect to privacy.
We have all been touched by breast and ovarian cancers whether directly by a personal diagnosis or indirectly through our family members, friends, colleagues or neighbours. Breast and ovarian cancers are complex, complicated, and multifaceted by nature. Education is a powerful and valuable tool. With medical knowledge and technology rapidly developing, what is the future direction for breast and ovarian cancer screening and detection? What are the most up-to-date choices for patients? What role does genetics play, and what are the advances in risk assessment, prevention and diagnosis?
When:
Thursday, April 23, 2009, 7:15 - 9:30 a.m.
Where:
Collaboration Centre Auditorium
MaRS Discovery District
101 College Street, Toronto
Dr. Rosen is a highly respected Gynecologic Oncologist and serves as Director of The Familial Breast and Ovarian Cancer Clinic, Department of Gynecology-Oncology, Princess Margaret Hospital, The University Health Network. Concurrently Dr. Rosen is the Head, Division of Gynecologic Oncology and Associate Professor, Dept. of Obstetrics and Gynecology, University of Toronto. Barry Rosen is a valued Fellow of the Royal College of Surgeons of Canada (FRCSC) and served with distinction as past President of The Society of Gynecologic Oncologists of Canada. Dr. Rosen has developed special clinical and research interests in hereditary ovarian cancer and the development of gyn-oncology databases that integrate patient medical records for clinical research purposes.
Dr. Bernardini is a graduate of the University of Western Ontario. He completed a residency program in the Department of Obstetrics and Gynecology at the University of Toronto. During this time Dr. Bernardini also obtained a Masters of Science degree through the Clinical Investigator Program. In 2007, Dr. Bernardini was awarded the prestigious RBC Foundation/McArthur/Genesis Research Foundation Fellowship in Gynaecologic Oncology. Dr. Bernardini completed his Fellowship in Gynecologic Oncology in 2008 through the University of Toronto, which included training at Duke University Medical Center (US). He is presently a Gynecologic Oncologist in the Department of Gynecology-Oncology, Princess Margaret Hospital, The University Health Network and is an Assistant Professor in the Department of Obstetrics and Gynecology at the University of Toronto.
Dr. Messner earned her MD at McMaster University, Hamilton, BSc at McGill University, Montreal and MSc at the University of Toronto. Dr. Messner is a distinguished Fellow of the College of Family Physicians (FCFP). Currently Dr. Messner is a Clinician, Researcher and Medical Coordinator, Clinical Breast Services, Preventive Oncology, Toronto Sunnybrook Health Sciences Centre, Odette Cancer Centre and Women's College Hospital. As a noted breast specialist and highly regarded speaker for women's health, Sandra Messner's special interest and primary focus is breast cancer risk, prevention and diagnosis specific to women and families with hereditary breast cancer.
